63286-11-3 Usage
Uses
Used in Pharmaceutical Industry:
3-Methyl-1-pyridin-2-yl-piperazine is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure allows it to be a key component in the development of new drugs, particularly in the area of central nervous system medications.
Used in Drug Discovery:
3-Methyl-1-pyridin-2-yl-piperazine is employed as a starting material in drug discovery processes. Its structural properties make it a valuable candidate for the creation of potential therapeutic agents, with applications in various medical fields.
Used in Chemical Research:
3-Methyl-1-pyridin-2-yl-piperazine is used as a research compound in the field of organic chemistry. Its synthesis and properties are of interest to scientists studying the reactivity and behavior of piperazine derivatives, which can lead to advancements in chemical synthesis techniques and the discovery of new compounds with potential applications.
Check Digit Verification of cas no
The CAS Registry Mumber 63286-11-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,2,8 and 6 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 63286-11:
(7*6)+(6*3)+(5*2)+(4*8)+(3*6)+(2*1)+(1*1)=123
123 % 10 = 3
So 63286-11-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H15N3/c1-9-8-13(7-6-11-9)10-4-2-3-5-12-10/h2-5,9,11H,6-8H2,1H3
63286-11-3Relevant academic research and scientific papers
Nickel-catalysed selective N-arylation or N,N′-diarylation of secondary diamines
Brenner, Eric,Schneider, Rapha?l,Fort, Yves
, p. 6913 - 6924 (2007/10/03)
The selective synthesis of N-aryl or N,N′-diaryl piperazines and trimethylene(bis)piperidines from the corresponding diamines and aryl chlorides using a catalyst combination of Ni(0) associated to 2,2′-bipyridine is described. The Ni/2,2′-bipyridine catalyst is also effective for the sequential arylation of piperazine. The preparation of novel and unsymmetrical 1,4-diaryl piperazines is reported.
